Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
accuracy, Aerospace, agreeing, ambit, ambulatory, ANGO, appellate, area, bad, Ball, Bausch, began, birth, career, central, colloquially, complementary, concurrent, curb, Dave, David, deficiency, dosing, dynamic, endoclear, engineering, enterprise, escalating, ESPP, Extreme, factual, Greiner, immaterial, implicit, indeterminate, intraperiod, irrevocably, led, Lomb, Medtronic, Michael, NASDAQ, neomed, neonatal, Obamacare, obsolescence, overhead, oversaw, par, pediatric, persist, played, proportion, publicly, redeem, redeemed, rent, resource, retention, rose, situation, stabilization, stabilize, stabilizing, stage, Summit, travel, trend, unspecified, unsuccessful, vacate, Vistaprint, Water, widespread, Wyeth
Filing tables
Filing exhibits
Related press release
Associated AVNS transcripts
AVNS similar filings
Filing view
External links
Exhibit No. 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-199748 and 333-233071 on Form S-8 of our reports dated February 25, 2020, relating to the consolidated financial statements of Avanos Medical, Inc. and subsidiaries (the “Company”), and the effectiveness of the Company’s internal control over financial reporting, appearing in this Annual Report on Form 10-K of Avanos Medical, Inc. for the year ended December 31, 2019.
/s/ DELOITTE & TOUCHE LLP |
Deloitte & Touche LLP |
Atlanta, Georgia |
February 25, 2020 |